Galectin Therapeutics Inc (GALT)
NASDAQ:GALT
Holding GALT?
Track your performance easily

Galectin Therapeutics (GALT) Ownership - Who Owns Galectin Therapeutics?

561 Followers

Galectin Therapeutics (GALT) Ownership Overview

28.08%4.62%0.54%4.46%62.29%
28.08% Insiders
0.54% Other Institutional Investors
4.46% ETFs
62.29% Public Companies and
Individual Investors
The ownership structure of Galectin Therapeutics (GALT) stock is a mix of institutional, retail, and individual investors. Approximately 9.63% of the company’s stock is owned by Institutional Investors, 28.08% is owned by Insiders, and 62.29% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Oct 23, 2024
Kary Eldred
Director
xxxxxxxxxxxxx
$1300
Oct 17, 2024
xxxxxxxxxxxxx
$3432
Oct 16, 2024
xxxxxxxxxxxxx
$27000
Aug 26, 2024
xxxxxxxxxxxxx
$8050

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
10,296,461Insider16.53%28,933,055
5,922,207Insider9.51%16,641,402
2,028,390Institution3.26%5,699,776
1,917,722Institution3.08%5,388,799
899,012Insider1.44%2,526,224
606,068Institution0.97%1,703,051
482,923Institution0.78%1,357,014
202,383Institution0.32%568,696
132,832Insider0.21%373,258
99,231Institution0.16%278,839

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,917,722Institution3.08%5,388,799
482,923Institution0.78%1,357,014
202,383Institution0.32%568,696
99,231Institution0.16%278,839
65,073Institution0.10%182,855
37,318Institution0.06%104,864
27,623Institution0.04%77,621
26,902Institution0.04%75,595
8,500Institution0.01%23,885
5,516Institution<0.01%15,500

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,247,562Institution2.00%3,430,796
670,160Institution1.08%1,842,940
377,801Institution0.61%1,061,621
107,225Institution0.17%301,302
93,332Institution0.15%256,663
75,954Institution0.12%208,874
74,115Institution0.12%208,263
51,484Institution0.08%134,116
46,927Institution0.08%131,865
11,769Institution0.02%32,365

FAQ

Who Owns Galectin Therapeutics Inc (GALT)?
According to the latest TipRanks data, approximately 0.54% of the company's stock is held by institutional investors, 28.08% is held by insiders, and 62.29% is held by retail investors.
    What percentage of Galectin Therapeutics Inc (GALT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.54% of Galectin Therapeutics Inc (GALT) stock is held by institutional investors.
      What percentage of Galectin Therapeutics Inc (GALT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 62.29% of Galectin Therapeutics Inc (GALT) stock is held by retail investors.
        Who owns the most shares of Galectin Therapeutics Inc (GALT)?
        Richard E Uihlein owns the most shares of Galectin Therapeutics Inc (GALT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis